Fulvestrant Treatment Is Associated With Cholesterol Plasma Level Reduction in Hormone Receptor-Positive Metastatic Breast Cancer Patients
Cancer Biology and Therapy - United States
doi 10.4161/cbt.8.15.8959
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2009
Authors
Publisher
Informa UK Limited